Leydig cell insufficiency, postpubertalE23.0

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Androgen deficiency due to reduced pituitary LH/ICSH of unknown etiology; androgen-dependent strongly reduced fructose concentration in the ejaculate with strongly reduced fertility (see fertility disorder); otherwise normal male habitus, normal testicular size and normozoospermia.

TherapyThis section has been translated automatically.

Hormone substitution with HCG (e.g. Predalon) 5000 IU/week i.m. and HMG (e.g. Menogon) 3 times/week 150 IU until normalization of fructose in the ejaculate. If necessary, testosterone substitution with testosterone nantate (e.g. Testoviron depot 50), initial 50 mg/month i.m., slowly increase dose within 1-2 years to 250 mg/month i.m.

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer